217 results
8-K
EX-99.1
GOVX
Geovax Labs Inc
1 Mar 24
GeoVax Reports 2023 Year-End Financial Results
4:09pm
execution of our long-term strategy, with an end goal to bring unique, patented products to market, unmet medical needs. We look forward to reporting … condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements
POS AM
GOVX
Geovax Labs Inc
1 Mar 24
Prospectus update (post-effective amendment)
4:04pm
Review Voucher program
Our corporate strategy is to advance, protect and exploit our differentiated vaccine/immunotherapy technologies leading … , our business and operations may be adversely affected.
The success of our business strategy will depend to a significant degree upon the continued
POS AM
91btm8w
1 Mar 24
Prospectus update (post-effective amendment)
4:04pm
POS AM
5amiq08ja fwhl
1 Mar 24
Prospectus update (post-effective amendment)
4:03pm
POS AM
zx5r7iyesoe09x
1 Mar 24
Prospectus update (post-effective amendment)
4:03pm
424B3
472ufp
12 Jan 24
Prospectus supplement
4:00pm
8-K
EX-99.1
3iy5p8wfzcwprtfse9t6
9 Nov 23
GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update
12:40pm
424B3
ul7rl0yrmu
8 Nov 23
Prospectus supplement
4:04pm
424B3
1r78xsl 8ea
8 Nov 23
Prospectus supplement
4:03pm
424B3
s44lxo
8 Nov 23
Prospectus supplement
4:01pm
8-K
EX-99.1
5o3gzstbqrkmi gly4cc
10 Aug 23
GeoVax Reports 2023 Second Quarter Financial Results
9:45am
424B5
1hh50j49 vpro3azp
18 Jul 23
Prospectus supplement for primary offering
4:13pm